Trial intelligence / Profile preview

Effects of rifampicin on glucose, lipid, and hormone homeostasis in healthy volunteers

2009-013704-31Phase 4Completed

Sponsor
Oulu University Hospital
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of rifampicin, sponsored by Oulu University Hospital. Primary endpoints: Change in HOMA-IR index, Change in fasting glucose and 1 more. Started Jul 2009; status: completed.

02

Drugs

rifampicin

Beyond the preview

Go deeper on 2009-013704-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013704-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call